Pharma has turned its attention to health equity with razor-sharp focus in recent years.
A new wave of strategies are beginning to flood the industry, including better approaches to recruiting diverse populations, attempts to overcome negative perceptions of research and efforts to take trials directly to patient communities.
INCLUDED IN THIS TRENDLINE
Offered Free by: PharmaVoice and PINC AI Applied Sciences
See All Resources from: PharmaVoice and PINC AI Applied Sciences